Skip to main content
Top

Drugs

Issue 3/2015

Content (8 Articles)

Tedizolid: A Novel Oxazolidinone with Potent Activity Against Multidrug-Resistant Gram-Positive Pathogens

  • Review Article

George G. Zhanel, Riley Love, Heather Adam, Alyssa Golden, Sheryl Zelenitsky, Frank Schweizer, Bala Gorityala, Philippe R. S. Lagacé-Wiens, Ethan Rubinstein, Andrew Walkty, Alfred S. Gin, Matthew Gilmour, Daryl J. Hoban, Joseph P. Lynch 3rd, James A. Karlowsky

Pemphigus Vulgaris: An Evidence-Based Treatment Update

  • Systematic Review

Cathy Y. Zhao, Dedee F. Murrell

Blinatumomab: First Global Approval

  • R&D Insight Report

Mark Sanford

Secukinumab: First Global Approval

  • R&D Insight Report

Mark Sanford, Kate McKeage

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images